Institut Pasteur Korea (IP-K) has signed an agreements to continue to mine the chemical compound collection of Novartis Institute for Tropical Diseases (NITD) of Singapore for new drug candidates. IP-K's PhenomicScreen™ is a high-throughput, high-content visual screening platform that is ideally...